Evidence map›Paper›PMID 29553831›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2018

Exosomes from asbestos-exposed cells modulate gene expression in mesothelial cells.

Phillip Munson, Ying-Wai Lam, Julie Dragon, Maximilian MacPherson, Arti Shukla

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. In vitro models of exosome biology and toxicology: New frontiers in biomedical research.Toxicology in vitro : an international journal published in association with BIBRA · 2020
    Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Phillip MunsonDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, Vermont, USA.
Ying-Wai LamDepartment of Biology, University of Vermont, Burlington, Vermont, USA.
Julie DragonDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.
Maximilian MacPhersonDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, Vermont, USA.
Arti ShuklaDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, Vermont, USA.
University of Vermont · USVermont Oxford Network · US

Funding

Vermont INBRE Administrative Supplement 2024 AWD 118P20GM103449 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI CHRISTOPHER S FRANCKLYN · 2012 to 2026
$58.4M
VERMONT IMMUNOBIOLOIGY/ INFECTIOUS DISEASES CENTERP20RR021905 · NCRR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2006 to 2011
$14.5M
Vermont Immunology/Infectious Diseases CenterP30GM118228 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2016 to 2021
$6.8M
Inflammasomes in pathogenesis of mesotheliomaR01ES021110 · NIEHS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SHUKLA, ARTI · 2012 to 2016
$1.7M
NCRR NIH HHS P20 RR021905NIEHS NIH HHS R01 ES021110NIGMS NIH HHS P20 GM103449NIGMS NIH HHS P30 GM118228
6 · The paper itself

Abstract

Asbestos exposure is a determinate cause of many diseases, such as mesothelioma, fibrosis, and lung cancer, and poses a major human health hazard. At this time, there are no identified biomarkers to demarcate asbestos exposure before the presentation of disease and symptoms, and there is only limited understanding of the underlying biology that governs asbestos-induced disease. In our study, we used exosomes, 30-140 nm extracellular vesicles, to gain insight into these knowledge gaps. As inhaled asbestos is first encountered by lung epithelial cells and macrophages, we hypothesize that asbestos-exposed cells secrete exosomes with signature proteomic cargo that can alter the gene expression of mesothelial cells, contributing to disease outcomes like mesothelioma. In the present study using lung epithelial cells (BEAS2B) and macrophages (THP-1), we first show that asbestos exposure causes changes in abundance of some proteins in the exosomes secreted from these cells. Furthermore, exposure of human mesothelial cells (HPM3) to these exosomes resulted in gene expression changes related to epithelial-to-mesenchymal transition and other cancer-related genes. This is the first report to indicate that asbestos-exposed cells secrete exosomes with differentially abundant proteins and that those exosomes have a gene-altering effect on mesothelial cells.-Munson, P., Lam, Y.-W., Dragon, J. MacPherson, M., Shukla, A. Exosomes from asbestos-exposed cells modulate gene expression in mesothelial cells.

Indexed as

AsbestosCarcinogensCell LineEpithelial CellsEpithelial-Mesenchymal TransitionEpitheliumExosomesGene ExpressionHumansInhalation ExposureLungMacrophagesAsbestosCarcinogensbiomarkersextracellular vesiclesmesotheliomaproteomicstumorigenesis

Identifiers

PMID29553831
PMCPMC6044058
OpenAlexW2789275942

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.